What does DR. LIESBETH CORNELISSEN do?

DR. LIESBETH CORNELISSEN is a specialist medical practice in Mol. Private Limited, started on 7 January 2015, 1 establishment.

What is the address of DR. LIESBETH CORNELISSEN?

The registered office of DR. LIESBETH CORNELISSEN is located at Duivelsbroek 13, 2400 Mol.

Is DR. LIESBETH CORNELISSEN still active?

Yes. According to the CBE (28 September 2026) DR. LIESBETH CORNELISSEN is active, legal situation “Normale toestand”, started on 7 January 2015.

Is DR. LIESBETH CORNELISSEN registered on Peppol?

Yes, DR. LIESBETH CORNELISSEN is registered on the Peppol network with ID 0208:0507981179.

What is the enterprise number of DR. LIESBETH CORNELISSEN?

The enterprise number of DR. LIESBETH CORNELISSEN is BE0507981179.

When was DR. LIESBETH CORNELISSEN founded?

DR. LIESBETH CORNELISSEN was founded on 7 January 2015.

Who are the directors of DR. LIESBETH CORNELISSEN?

According to the 2025 annual accounts, the directors of DR. LIESBETH CORNELISSEN are: Liesbeth CORNELISSEN.

Is DR. LIESBETH CORNELISSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. LIESBETH CORNELISSEN make in 2025?

DR. LIESBETH CORNELISSEN posted a profit after taxes of € 419,872 in financial year 2025.

What is the revenue of DR. LIESBETH CORNELISSEN?

As a small company, DR. LIESBETH CORNELISSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 577,931.

DR. LIESBETH CORNELISSEN (Private Limited) - Mol

Dossier DR. LIESBETH CORNELISSEN, printed on 28 September 2026 from databakkes.be/en/0507981179/dr-liesbeth-cornelissen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. LIESBETH CORNELISSEN from Mol, company number BE0507981179, closed financial year 2025 with a result of € 419,872 after tax. For that financial year DR. LIESBETH CORNELISSEN recorded a gross margin of € 577,931 and equity of € 18,600. Compared with financial year 2024, the result moved from € 426,138 to € 419,872. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 11, 2026.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 419,872

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 368,826

▲ € 283,884 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 419,872 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 1,452

▼ 34% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 38,690

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 70,015

▼ 21% vs 2024

€ 18,678 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,983

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 53,223

▲ 38% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 500,239 Gross margin 2022: € 500,239 First fiscal year in the series	€ 567,560 Gross margin 2023: € 567,560 ▲ 13% vs 2022 (€ 500,239) Favourable step	€ 586,142 Gross margin 2024: € 586,142 ▲ 3% vs 2023 (€ 567,560) Favourable step	€ 577,931 Gross margin 2025: € 577,931 ▼ 1% vs 2024 (€ 586,142) Unfavourable step	▼ 1%
Profit after taxes	€ 373,972 Profit after taxes 2022: € 373,972 First fiscal year in the series	€ 413,005 Profit after taxes 2023: € 413,005 ▲ 10% vs 2022 (€ 373,972) Favourable step	€ 426,138 Profit after taxes 2024: € 426,138 ▲ 3% vs 2023 (€ 413,005) Favourable step	€ 419,872 Profit after taxes 2025: € 419,872 ▼ 1% vs 2024 (€ 426,138) Unfavourable step	▼ 1%
Equity	€ 18,600 Equity 2022: € 18,600 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2024: € 18,600 Unchanged (€ 18,600) Unchanged	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 448,846 Total debts 2022: € 448,846 First fiscal year in the series	€ 568,893 Total debts 2023: € 568,893 ▲ 27% vs 2022 (€ 448,846) Unfavourable step	€ 564,420 Total debts 2024: € 564,420 ▼ 1% vs 2023 (€ 568,893) Favourable step	€ 558,356 Total debts 2025: € 558,356 ▼ 1% vs 2024 (€ 564,420) Favourable step	▼ 1%
Cash	€ 310,205 Cash 2022: € 310,205 First fiscal year in the series	€ 105,331 Cash 2023: € 105,331 ▼ 66% vs 2022 (€ 310,205) Unfavourable step	€ 84,942 Cash 2024: € 84,942 ▼ 19% vs 2023 (€ 105,331) Unfavourable step	€ 368,826 Cash 2025: € 368,826 ▲ € 283,884 vs 2024 (€ 84,942) Favourable step	▲ € 283,884
Dividend	€ 375,832 Dividend 2022: € 375,832 First fiscal year in the series	€ 413,005 Dividend 2023: € 413,005 ▲ 10% vs 2022 (€ 375,832) Unchanged	€ 426,138 Dividend 2024: € 426,138 ▲ 3% vs 2023 (€ 413,005) Unchanged	€ 419,872 Dividend 2025: € 419,872 ▼ 1% vs 2024 (€ 426,138) Unchanged	▼ 1%
Bank debt	€ 28,333 Bank debt 2022: € 28,333 First fiscal year in the series	€ 105,414 Bank debt 2023: € 105,414 ▲ 272% vs 2022 (€ 28,333) Unfavourable step	€ 88,118 Bank debt 2024: € 88,118 ▼ 16% vs 2023 (€ 105,414) Favourable step	€ 70,015 Bank debt 2025: € 70,015 ▼ 21% vs 2024 (€ 88,118) Favourable step	▼ 21%
Balance sheet total	€ 467,446 Balance sheet total 2022: € 467,446 First fiscal year in the series	€ 587,493 Balance sheet total 2023: € 587,493 ▲ 26% vs 2022 (€ 467,446) Unchanged	€ 583,020 Balance sheet total 2024: € 583,020 ▼ 1% vs 2023 (€ 587,493) Unchanged	€ 576,956 Balance sheet total 2025: € 576,956 ▼ 1% vs 2024 (€ 583,020) Unchanged	▼ 1%

Key figures of DR. LIESBETH CORNELISSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LIESBETH CORNELISSEN?

What happened at DR. LIESBETH CORNELISSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 11, 2026 New annual accounts for financial year 2025: profit of € 419,872 (▼ 1% vs 2024). Source: NBB ↗
Jan 7, 2015 New establishment in Geel. KBO
Jan 7, 2015 Start of the company according to the CBE. KBO
2015 Liesbeth CORNELISSEN became a director. NBB

In short

From € 373,972 profit in 2022 to € 419,872 profit in 2025.

Paid € 526,450 in corporate taxes since 2022.

Best year ever: 2024, with € 426,138 profit.

Paid out € 1.6 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LIESBETH CORNELISSEN? We notify you, reason included.

Follow DR. LIESBETH CORNELISSEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Liesbeth CORNELISSEN

DR. LIESBETH CORNELISSEN

Behind DR. LIESBETH CORNELISSEN is Liesbeth CORNELISSEN.

See the full network in the app

Directors

According to the 2025 annual accounts

Liesbeth CORNELISSEN

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Duivelsbroek 13

2400 Mol

2.238.281.631

J.B.-Stessensstraat 2

2440 Geel

Active since 7 January 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0507.981.179
VAT number: BE 0507.981.179
Registered office: Duivelsbroek 13, 2400 Mol
Names & denominations: DR. LIESBETH CORNELISSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2015
Peppol: Active · Active since 23 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗